Ana Beltran-Bless profile picture

Contact Information

Ana Beltran-Bless

Publications

Selected Publications



All Other Publications

Kababji, S., Mitsakakis, N., Fang, X., Beltran-Bless, A., Pond, G., Vandermeer, L., Radhakrishnan, D., Mosquera, L., Paterson, A., Shepherd, L., Chen, B., Savard, M.F., Clemons, M., El Emam, K. Evaluating the Utility and Privacy of Synthetic Breast Cancer Clinical Trial Datasets. JCO Clinical Cancer Informatics. November 27 2023. doi/full/10.1200/CCI.23.00116

Beltran-Bless, A., Kacerovsky-Strobl, S., Gnant, M., Explaining risks and benefits of loco-regional treatments to patients. The Breast. 22 August 2023. https://doi.org/10.1016/j.breast.2023.08.006

Beltran-Bless, A., Clemons, M. How Frequently Should Patients with Breast Cancer Have Routine Follow-up Visits? New England Journal of Medicine Evidence. July 25 2023.

Beltran-Bless, A., Alshamsan, B., Azahrani, M., Baines, K., Samuel, V., Pond, G., Vandermeer, L., Clemons, M., Hilton, J., Larocque, G. Regularly scheduled physical examinations and the detection of breast cancer recurrences. The Breast. March 2023. doi: 10.1016/j.breast.2023.03.004

Beltran-Bless A, Clemons, M., Fesl, C., Greil, R., Pond, G.R., Balic, M., Vandermeer L., Bjelic-Radisic. V., Singer, C.F, Steger, GG., Helfgott, R., Egle D., Solkner L., Gampeireider S.P., Kacerovsky-Strobl, S., Suppan, C., Ritter, M., Rinnerthaler, G., Pfeiler, G., Fohler, H., Hlauschek, D., Hilton, J., Gnant, M. Does the number of 6-monthly adjuvant zoledronate infusions received affect treatment efficacy for early breast cancer? A sub-study of ABCSG-12. European Journal of Cancer. Dec 2022. PMID: 36592505. doi: 10.1016/j.ejca.2022.12.003

Beltran-Bless, A., Ng, T. Race, ethnicity, and clinical outcomes in hormone receptor-positive, human epidermal growth factor 2 negative (HER2−), node negative breast cancer in the randomized TAILORx trial: gaps in biologic and social determinants of health. Annals of Translation Medicine. Dec 2022. https://atm.amegroups.com/article/view/104954.

Beltran Bless, A., Murshed, M., Zakikhani, M., Kuchuk, I., Bouganim N., Robertson, S., Kekre N., Vandermeer, L., Li, J., Addison, C.L, Rauch F., Clemons, M., Kremer, R.. Histomorphometric and microarchitectural analysis of bone in metastatic breast cancer patients. Bone Reports. Dec 2021. PMID: 34841014. https://doi.org/10.1016/j.bonr.2021.101145.

Bradbury, M., Hutton, B., Beltran-Bless, A., AlZahrani M., Lariviere, T., Fernandes, R., Ibrahim, M., Cole, K., Hilton, J., Vandermeer, L., Shorr, R., Larocque, G., Clemons, M. Time to update evidence-based guideline recommendations about concurrent tamoxifen and antidepressant use? A systematic review. PMID: 34740542. Oct 2021. Clinical breast cancer. https://doi.org/10.1016/j.clbc.2021.10.003.

Beltran-Bless, A., Vandermeer L, Ibrahim MFK, Hutton B, Shorr R, Savard M-F, Clemons M. Does the Time of Day at Which Endocrine Therapy Is Taken Affect Breast Cancer Patient Outcomes? Current Oncology. Jul 2021. 28(4):2523-2528. PMID: 3428726. https://doi.org/10.3390/curroncol28040229

Beltran-Bless, A., Vandermeer B, Paterson A, Gunstone I, Kaizer L, Arnaout A, Vandermeer L, Clemons M. Lost in Transition? Thoughts on Retirement, Part 2. "Should I Stay or Should I Go Now?" Oncologist. 2021 May 4. PMID: 33942937. doi: 10.1002/onco.13808. Epub ahead of print.

Surujballi J, Shah H, Hutton B, Alzahrani M, Beltran-Bless, A., Shorr R, Larocque G, McGee S, Cole K, Ibrahim MFK, Fernandes R, Arnaout A, Stober C, Liu M, Sienkiewicz M, Saunders D, Vandermeer L, Clemons M. The COVID-19 pandemic: An opportunity to rethink and harmonise the frequency of follow-up visits for patients with early-stage breast cancer. Cancer Treat Rev. 2021 Jun;97:102188. PMID: 33813329. doi: 10.1016/j.ctrv.2021.102188.

Beltran-Bless, A., Ng, T. A narrative review of immune checkpoint inhibitors in early-stage triple negative breast cancer. Precision Cancer Medicine. 2021 Mar 30. doi:10.21037/pcm-20-64

Beltran-Bless A, Bouganim N. Significant clinical response induced by vismodegib in advanced sarcoma: Hedgehog pathway inhibition. Fall 2019. Sarcoma Journal. https://www.curesarcoma.org/wp-content/uploads/TSJ_FALL-ISSUE-2019.pdf

PubMed Listings

For more publications use this PubMed ID link.